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Abstract Treatment of symptomatic pharyngeal and
esophageal strictures requires endoscopic dilatation. The
Savary-Gilliard bougienage was developed by our depart-
ment and has been used since 1980 for this purpose. We
report our experience using this technique. The records of
patients seen from January 1, 1963 to December 31, 2005,
who had pharyngeal and esophageal strictures needing dila-
tation, were reviewed. The prevalence of diVerent etiolo-
gies, and the incidence of complications using the Savary-
Gilliard dilators were assessed. EYciency of dilatation was
assessed over a 17-year segment of this period, using num-
ber of dilatations and time intervals between dilatations
until resolution of symptoms as outcome measures. Of the
2,652 pharyngeal and esophageal strictures reviewed, 90%
were of organic origin (45% benign and 55% malignant ste-
noses), and 10% were of functional etiology. The most
common etiologies were peptic strictures before the era of
proton pump inhibitors, and postoperative anastomotic
strictures thereafter. A total of 1,862 dilatations using the
Savary-Gilliard technique were analyzed. Complication
and mortality rates were 0.18 and 0.09% for benign and
4.58 and 0.81% for malignant etiologies, respectively. The
number of dilatations per stricture and the time interval
between diVerent sessions were dependent on the type of
strictures, varying from 1 to 23 dilatations and 7 days to
16 years, respectively. Pharyngeal and esophageal dilata-
tions using the Savary-Gilliard technique were safe when
used together with Xuoroscopy. Overall, the eYciency of
the dilatation procedure was good, but some types of stric-
tures (e.g., caustic, post-surgical and/or post radiotherapy)
were refractory to treatment and required repeated dilatations.
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Introduction
Patients with hypopharyngeal and esophageal strictures ini-
tially present with dysphagia to solids, which progresses to
liquids over time. The degree of dysphagia is correlated
with the size of the esophageal lumen: a diameter less than
12 mm always produces dysphagia with consumption of a
normal diet. Other symptoms may include chest or abdomi-
nal pain, weight loss and possibly regurgitation and aspira-
tion if the stricture is located in the upper esophagus.
Esophageal strictures can be divided grossly into two
categories, according to their benign or malignant etiology.
Among the benign strictures, functional and organic origins
must be distinguished: functional strictures are the conse-
quence of increased tonicity of the muscular wall while
benign organic strictures mainly result from collagen
deposits and Wbrous tissue formation induced by mucosal
injuries of diverse origins.
Endoscopy to obtain a biopsy specimen is mandatory for
excluding neoplasm and assessing stricture characteristics.
Length, precise location regarding upper and lower esopha-
geal sphincters, spontaneous lumen diameter and mucosal
appearance should be evaluated. Strictures are considered
complex when they are greater than 2 cm in length or are
angulated, irregular or do not allow the passage of a pediat-
ric endoscope [8].
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benign esophageal strictures. In malignant strictures, no
attempt should be made to pass the stricture with forceful
dilatation in order to avoid the risk of perforation, unless
the tumor is short and requires that EUS endoscope be
inserted to perform the initial staging of the tumor, or in
palliative treatment with or without esophageal prosthesis
placement.
Dilatations using carved whalebone were Wrst reported
in the seventeenth century [33], and numerous dilators have
since been developed. Mercury-Wlled Maloney dilators are
Xexible bougies without guide wires that are used for blind
dilatation of simple strictures. Wire-guided dilators include
the Eder-Puestow metal olives, which are now obsolete, the
Savary-Gilliard polyvinyl-chloride bougies and the balloon
dilators. The Savary-Gilliard technique was developed in
the Department of Otolaryngology, Head and Neck Sur-
gery, University Hospital of Lausanne in 1980, with the
aim of decreasing the perforation rate, which then varied
from 0.5 to 9%, depending on the dilatation system and the
reported series [10, 22]. Another widely used system is the
through-the-scope balloon dilator, which exerts only radial
forces during dilatation and can be advantageous in some
instances.
The purpose of this retrospective study was to review the
records of all patients in our department, diagnosed with
pharyngeal and esophageal strictures from 1963 through
2005, and to assess the safety and eYcacy of the dilatations
performed with the Savary-Gilliard technique since its
introduction in 1980.
Materials and methods
Our database was reviewed to assess number and etiologies
of the pharyngeal and esophageal strictures necessitating
dilatation in our department between January 1, 1963 and
December 31, 2005. Dilatations with the Savary-Gilliard
dilators have been exclusively used in our clinic since
1980, rather than using the Maloney dilators or the Eder-
Puestow olives, except for some cases of achalasia that
were managed by balloon dilatation. The Savary-Gilliard
set included a metallic guide-wire and polyvinyl chloride
bougies, ranging from 5 to 18 mm in diameter. The proce-
dure has been described in detail elsewhere [26], and was
always performed under Xuoroscopy.
Results of dilatation using this procedure were reported
as the number of dilatations per stricture and the time inter-
val between the diVerent sessions over a 17-year period
(January 1, 1989 to December 31, 2005). These two factors
were directly related to the eYciency of dilatation. In our
institution, patients without relief of symptoms or in whom
a lumen of 15 mm in diameter could not be obtained after
the Wrst dilatation were included in a dilatation program.
This consisted of repeated dilatations every third week until
permanent improvement was obtained. Patients for whom
the Wrst procedure was satisfactory were followed up and
dilated only if dysphagia recurred. In case of gastroesopha-
geal reXux disease (GERD)-induced strictures, the dilata-
tion was followed by a proton pump inhibitor (PPI)
treatment. Patients with achalasia were excluded from the
analysis of results because of intermittent balloon dilata-
tions. Neither were included strictures treated by other tech-
niques in combination with dilatation, as CO2 laser for
example.
Complications of dilatations were reported from Janu-
ary 1, 1980 to December 31, 2005. Severe complications
were deWned as potentially life-threatening situations and
were assessed by reviewing the surgeon’s endoscopy
report. If the surgeon’s report described any complica-
tions, then the patient’s complete medical records were
reviewed to determine any long-term eVects of the com-
plications.
Results
The retrospective analysis of our database showed a total of
2,652 pharyngeal or esophageal strictures requiring dilata-
tion from 1963 to the end of 2005. There were 2,374 (90%)
organic strictures, among which 1,071 (45%) were of
benign and 1,303 (55%) of malignant origin. Squamous cell
carcinoma of the esophagus was by far the most frequent
malignant etiology (38%), followed by esophageal or gas-
tric adenocarcinoma (20%), and pharyngeal squamous cell
carcinoma (5%).
Etiologies for benign organic strictures are reported in
Table 1. Non-organic or functional origins represented 10%
of the data, with a total of 278 strictures. These were further
divided into cricopharyngeal hypertonia (50%), achalasia
(47%), and pylorus hypertonia after transhiatal esophagec-
tomy (3%).
The total prevalence of esophageal strictures requiring
dilatation among patients undergoing upper digestive
endoscopy was 6, 2.7% for benign organic, 3% for malig-
nant and 0.3% for functional strictures, respectively.
A total of 1,862 dilatations using the Savary-Gilliard
technique were performed, 1,120 (60%) for benign stric-
tures and 742 (40%) for malignant strictures. Dilatation was
followed by esophageal prosthesis placement in 457 cases
of neoplasia. Ninety-two (4.9%) procedures were per-
formed for pharyngeal strictures, the etiologies of which are
reported in Table 2.
The number of sessions per patient extended from 1 to
23 during the review period and was highly dependent upon
the etiology of the stenosis, as shown in Table 3. Time123
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as reported in Table 4.
Severe complications included esophageal perfora-
tion in 34 patients (1.83%), all but one presenting with
malignant strictures, and massive bleeding was docu-
mented in two patients (0.11%). The mortality rate was
0.38, 0.09% in benign and 0.81% in malignant strictures,
respectively, with death occurring in seven patients sec-
ondary to perforation. Our overall complication rate was
1.93, 0.18% for benign and 4.58% for malignant stric-
tures, respectively.
Discussion
Etiology of strictures
Benign strictures were primarily organic (79%), with
GERD-related strictures being the most frequent etiology
(43%). They accounted for 52% of the benign organic stric-
tures before 1989, but dropped to only 18% after this period
(Figs. 1, 2). The introduction of PPIs, commercialized in
1989, accounts for the fall in the prevalence of these lesions.
It is now well recognized that the use of PPIs decreases the
need for repeated dilatations in patients presenting with pep-
tic strictures [3, 23, 34]. This pathology is estimated to occur
in 7–23% of patients with untreated reXux esophagitis [29].
Endoscopically, peptic strictures are nearly always located
at the squamo-columnar junction (either at the Z-line, or at
the upper pole of a Barrett’s esophagus). They are generally
short and symmetrical, with frequent signs of proximal ero-
sive esophagitis. The initial stage of this esophageal narrow-
ing results from edema and muscular spasm and is reversible
with adequate antacid treatment. Progression of the disease
results in erosions and deep ulcerations, leading to scarring
of the submucosa and muscularis propria with narrowing of
the digestive tract [29].
Iatrogenic strictures are the second most common etiol-
ogy found in our series between 1963 and 2006. They rep-
resent 34% of our benign organic strictures. Since 1989,
Table 1 Features of benign organic strictures at CHUV from 1963 to
2006
RT Radiotherapy; CT chemotherapy; PDT phototherapy
Etiology Male Female Total (%)
Peptic 290 166 456 (42.58)
Iatrogenic 275 90 365 (34.08)
Post-RT § CT, post-PDT 53 21 74 (6.91)
Post-surgery 159 59 218 (20.35)
Post-surgery + RT 53 5 58 (5.42)
Post-sclerotherapy 7 2 9 (0.84)
Pill-induced 3 3 6 (0.56)
Caustic 36 36 72 (6.72)
Web 26 46 72 (6.72)
Schatzki’s ring 39 12 51 (4.76)
Undetermined 15 7 22 (2.05)
Pseudodiverticulosis 7 0 7 (0.65)
Epidermolysis bullosa 3 4 7 (0.65)
Ringed esophagus 4 1 5 (0.47)
Pemphigoid mucosynechiant 0 4 4 (0.37)
Candidiasis 3 0 3 (0.28)
Lichen planus 0 2 2 (0.18)
Submucosal Wbrosis 2 0 2 (0.18)
Scleroderma 0 1 1 (0.09)
Post traumatic 1 0 1 (0.09)
MyoWbromatosis 1 0 1 (0.09)
Total 702 369 1,071
Table 2 Etiologies of pharyn-
geal strictures dilated from 1989 
to 2006
Etiology n
Iatrogenic 42
Post-RT § CT 8
Post-surgery 7
Post-surgery + RT 27
Caustic 1
Post traumatic 1
Epidermolysis bullosa 1
Malignant 6
Total 51RT Radiotherapy; CT Chemotherapy
Table 3 Number of dilatations per stricture from 1989 to 2006
RT Radiotherapy
Etiology (number of strictures) Median Mean Range
Pill-induced (2) 1 1 1
Lichen planus (2) 1 1 1
Scleroderma (1) 1 1 1
Pseudodiverticulosis (3) 1 1 1
MyoWbromatosis (1) 1 1 1
Web (10) 1 1 1–2
Undetermined (15) 1 1 1–2
Pylorus hypertonia (6) 1 1 1–2
Epidermolysis bullosa (3) 1 1.5 1–3
Peptic (54) 1 2 1–9
Mycotic (3) 1 3 1–7
Submucosal Wbrosis (2) 1.5 1.5 1–2
Ringed esophagus (5) 2 1.5 1–2
Schatzki’s ring (4) 2 3 1–6
Post-surgery (78) 2 2.5 1–20
Post-RT (48) 2 3 1–17
Post-surgery + RT (58) 2 3 1–23
Caustic (14) 2.5 3.5 1–11
Post traumatic (1) 3 3 3123
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61% of the study sample. Apart from commercialization of
PPIs, there is a potential referential bias accounting for this
large number. Patients presenting with a history of upper
aerodigestive tract neoplasia are regularly followed up in
our department, or referred to us by digestive surgeons if
dysphagia recurs, whereas patients with GERD-related
problems may be referred by their attending physician to
the gastroenterology department rather than to Otolaryngol-
ogy. A majority of iatrogenic strictures are of postoperative
etiology, and this number increases with adjuvant therapy.
In our series, most of the postoperative strictures resulted
from esophagectomy, whereas in the group of combined
radio-surgical treatment, total laryngectomy and/or
pharyngo-laryngectomy predominated.
Benign strictures located at the esophago-gastric anasto-
mosis in the upper thorax have been reported to be a major
source of morbidity after transhiatal esophagectomy with a
prevalence of 5–46%, depending on the series. Risk factors
reported for developing such strictures are postoperative
anastomotic leaks, stapled anastomosis (possibly because
of insuYcient mucosal apposition), cardiac disease, and
poor vascularization of the gastric tube, the latter two
resulting in anastomotic ischemia [13, 28].
Post-radiotherapy strictures of the hypopharynx and
esophagus have been reported frequently and represented
12% of benign organic strictures in our series. The esopha-
gus is known to be a fragile and radiosensitive organ, and
late radiation injury is a common consequence of treatment
of head and neck, lung, esophageal and breast tumors.
Development of strictures is related to progressive oblitera-
tive endarteritis, ischemia and slowly developing Wbrosis
[18, 32]. The severity of strictures varies from a Wbrous ring
of the esophageal inlet to deep Wbrosis with possible subto-
tal obliteration of the lumen, which occurs generally in the
setting of hypopharyngeal tumors. There are numerous
Fig. 1 Etiologies of benign organic strictures from January 1, 1963 to
December 31, 1988
Peptic
53%
Caustic
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Web
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Table 4 Time interval between 
dilatations of strictures from 
1989 to 2006
Etiology 
(total number of strictures)
Median Mean Range
Schatzki’s ring (11) 4 years 4 years 2.5–6 years
Ringed esophagus (8) 5 months 20 months 2.5 months–4.5 years
Mycotic (9) 4 months 5.5 months 2.5–11 months
Peptic (102) 2 months 9.5 months 12 days–3 years
Post-surgery (198) 2 months 4.5 months 10 days–38 months
Post-RT (136) 2 months 4 months 9 days-7 years
Caustic (50) 1.5 months 9 months 14 days–16 years
Post-surgery + RT (176) 1.5 months 7 months 7 days–4 yearsRT Radiotherapy
Fig. 2 Etiologies of benign organic strictures from January 1, 1989 to
December 31, 2005
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ing radiation. The most important is the total absorbed
dose; doses greater than 60 Gy predispose the structures to
stricture formation [32]. Other factors include increased
volume of irradiation in locally advanced tumors and cir-
cumferential irradiation [24]. Lee et al. reported a 21%
prevalence of symptomatic strictures in a group of patients
primarily treated with concurrent chemoradiation therapy
for head and neck cancer. In this study, the risk factors
included radiation therapy performed twice daily, primary
tumors situated in the hypopharynx and female gender [19].
Although prevalence of strictures with concomitant chemo-
therapy has not been speciWcally investigated, the increased
mucosal toxicity of these treatments is well known, and a
higher degree of esophageal-wall Wbrosis can be expected
than after radiotherapy alone. Chronic xerostomy provoked
by oropharyngeal irradiation impedes acid neutralization in
the esophagus and may also predispose the patient to
esophagitis [17] and development of stricture. Another
evoked risk factor is prolonged enteral nutrition during
radiotherapy, explained by the decreased activity of the
hypopharyngeal and esophageal musculature predisposing
the area to mucosal adhesions and Wbrosis [9]. Percutane-
ous endoscopic gastrostomy has been suggested as a factor
that increases the need for dilatation when compared to
nasogastric tube, because of the lack of a stent-like eVect
[25]. Time of stricture onset after radiotherapy diVers,
according to the literature. Eisbruch et al. [6] assessed swal-
lowing disorders after chemoradiation therapy for head and
neck cancer in 26 patients and found that most strictures
developed 1–3 months post-treatment and remained stable
thereafter. Other authors have reported later onset of stric-
tures, with median values varying from 6 to 26 months after
radiotherapy [18, 32].
Pill-induced stricture is a rare condition (0.6% of our
series), but its incidence is likely to increase with aging of
the population and greater use of medication. This condi-
tion results from pill-induced esophagitis provoked by an
increase in time of contact with the mucosa when the drug
is ingested in a supine position or without enough intake of
water. Strictures are more likely to develop after KCl, quin-
idine, ferrous sulfate/succinate and alprenolol ingestion
[15]. Prevalence of strictures was 6% among the 51 cases
of pill-induced esophagitis diagnosed in our department
[27].
Esophageal strictures are one of the main complications
of caustic ingestion, the second being late cancerization.
Strictures develop during the scarring period 3–8 weeks
after ingestion, secondary to sclerosis and infection. Circu-
lar lesions or those involving the muscular layers (second
and third degree burns) are more prone to evolve into stric-
tures. They are more often provoked by alkali than by acid
ingestion, since the latter is mainly damaging the pharynx
and the stomach. These strictures represent 7% of our data
and have some speciWc endoscopic features. Among the 73
caustic strictures reviewed by Brossard et al. [4], 60% were
located in the upper esophagus, 48% were multiple and
49% measured more than 3 cm in length.
Webs are relatively frequent upper esophageal strictures
of unknown origin. They represent 7% of our benign organic
strictures with a female predominance (64%). According to
our data, upper esophageal webs are isolated entities. How-
ever, they have been associated with iron deWciency in
“Plummer-Vinson syndrome”. This entity is now largely
questioned, and its prevalence has been falling during the last
decade due to improvements in nutritional status [2].
Schatzki’s ring is a thin annulus present in the lower
esophagus, most of the time at the upper pole of a hiatal
hernia, representing 5% of our benign organic strictures.
Histologically, it is characterized by a proliferation of con-
nective tissue in the submucosa, most probably resulting
from GERD-carditis. It has a tendency to decrease in diam-
eter over time, and strictures less than 13 mm always pro-
voke dysphagia [31].
Intramural pseudodiverticulosis is a rare cause of benign
stricture predominantly aVecting men and representing less
than 1% of our data. Its prevalence has been reported to be
0.15% [21]. The features of this disease are dilatation of the
mucous gland excretory ducts from the submucosa, result-
ing in multiple intramural diverticula. Periglandular Wbrosis
and peridiverticulitis with associated stricture are present in
more than 90% of cases [12]. The pathogenesis is still
unknown, but increased incidences of candidiasis, GERD,
diabetes mellitus, chronic alcohol abuse and poor general
health, have been reported [7, 12].
Ringed esophagus, also called trachea-like or corrugated
esophagus is a condition of unknown origin aVecting young
men predominantly. It represents only 0.47% of our benign
strictures and is characterized by segmental strictures of
various lengths containing multiple submucosal rings that
are hard in consistency, generally without associated esoph-
agitis. Several studies have reported results from patients
with long-standing intermittent dysphagia, the so-called
“slow-eaters”, or with a history of food impaction [37].
When dilated, these strictures tend to show longitudinal
tears with little if any bleeding. This is a common feature of
this condition, which could be due to a submucosal Wbrosis,
possibly induced by recurrent episodes of fungal infection.
Other rare causes of benign strictures in our data are
reported in Table 1, and include several dermatologic dis-
eases, mycosis and sclerodermia.
Results of dilatations
Our review revealed a wide range of variability in
eYciency of dilatation as a function of the etiology of123
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each type of stricture. As expected, before the era of stent
placement, malignant strictures needed repeated dilatations
as tumors were regrowing, with a median interval of
2 months between interventions. The results of dilatations
of neoplastic strictures are highly dependent on the growth
rate of the tumor. Therefore, they were not compared to the
outcome of dilatations of benign strictures.
For benign strictures, eYciency of dilatations depended
upon the extent of involvement of the esophageal wall by
Wbrosis and inXammatory processes.
The group that responded poorest to dilatation included
caustic, postoperative and post-radiation therapy strictures.
During the 17-year period reviewed, the median number of
dilatations per patient was 2–2.5 (see Table 2), with a max-
imum of 23 dilatations for one patient. Median interval
between dilatations was between 1.5 and 2 months (see
Table 3), reXecting the high proportion of patients who
entered a dilatation program. According to our data, caustic
and post-surgery and/or post-radiotherapy strictures were
the most refractory to dilatation. This is in agreement with
the data reported in the literature [8].
Caustic strictures are known for their extension in length
and involvement of the entire thickness of the esophageal
wall. This results in tubulization of the scarred esophagus
with increased diYculty for eYcient dilatation. The out-
come of caustic-stricture dilatations in our department was
reported by Leuba et al. [20]. They found that when the
length of the stenosis is greater than 3 cm in the cranio-cau-
dal axis, management with dilatations is often insuYcient,
and indication for esophagectomy with coloplasty to restore
normal oral intake must be discussed if there is no improve-
ment of symptoms after a few dilatation sessions. Surgical
management must be taken into consideration especially in
young patients because of late cancerization.
Postoperative and postradiotherapy strictures also often
need repeat dilatations, and a combination of these two
treatment modalities further increases the number of dilata-
tions per stricture. Some patients may be dilated once and
then be asymptomatic, but most of them need multiple dila-
tations and inclusion in dilatation programs. Thereafter, the
frequency of repeat dilatations is dictated by recurrence of
dysphagia, with symptom-free intervals varying widely
from days to several years. The circular involvement and
the transmural Wbrosis due either to peri-anastomotic
inXammation, radiation or both, account for the tendency of
the lesion to recur.
Another distinct group includes webs, which usually
respond very well to dilatations. The median number of dil-
atations per stricture was one in this group, with a maxi-
mum of two dilatations per patient. A single dilatation is
suYcient for complete resolution of symptoms in most
patients.
Strictures related to dermatologic diseases, fungal infec-
tions, connectivitis or pill-induced strictures also tend to
respond well to dilatation, but their small number in this
sample does not allow us to draw any conclusions from the
data.
A third group of strictures, in which response to dilata-
tion is rather good but with frequent relapses, includes pep-
tic strictures, Schatzki’s rings and ringed esophagus.
The few cases of Schatzki’s rings and ringed esophagus
in our series generally required more than a single dilata-
tion (median 2) and had long-term recurrence. Neverthe-
less, the symptom-free period after a single dilatation was
4 years for Schatzki’s ring and 5 months for ringed esopha-
gus, which was much greater than for the refractory stric-
tures described previously. Moreover, patients do not have
to enter dilatation programs following this procedure. This
supports the eYcacy of a single dilatation for treatment of
these lesions, which, however, tend to form again with time
[14].
The majority of peptic strictures respond well to treat-
ment and can be dealt with by a single dilatation and PPI
oral intake. For patients necessitating several dilatations,
the median interval between procedures is 2 months (range
12 days to 3 years). This reXects the need for some patients
to enter a dilatation program, whereas others have a long
symptom-free interval and a late recurrence. This empha-
sizes the problem of patients’ compliance to long-term drug
intake, with the possible recurrence of stricture after years
because of PPI cessation.
Said et al. [30] performed a retrospective analysis of risk
factors for stricture recurrence within 1 year after symp-
tom-releasing dilatation in 87 patients presenting with
benign strictures. They showed an overall 40% recurrence
rate within 1 year, with several signiWcant risk factors.
Strictures with an initial diameter of 13 mm or below and
nonpeptic strictures were more prone to recur. Unfortu-
nately, diVerent etiologies of nonpeptic strictures were not
sorted out in the analysis, because, as mentioned previ-
ously, recurrences diVer widely depending upon the etiol-
ogy. Among peptic strictures, a greater recurrence was seen
in patients presenting with heartburn after dilatation, or a
hiatal hernia greater than 5 cm in length.
As far as localization of strictures is concerned, the out-
come after dilatation was overall better for esophageal than
for pharyngeal strictures, but the latter were mostly iatro-
genic in origin, belonging to the less favorable group. When
compared with esophageal strictures of iatrogenic origin, the
outcome of pharyngeal strictures was similar, conWrming that
the morphologic features of the lesion are more prominent
than its localization. However, there might be a potential
selection bias because some severe pharyngeal strictures
were managed in combination with CO2 laser radial inci-
sions. They were therefore excluded from the study.123
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Slight bleeding and mucosal erosions are frequently seen
after esophageal dilatations, and these conditions resolve
spontaneously without speciWc management. Nevertheless,
two severe and potentially life-threatening complications
may occur, namely esophageal perforation and hemateme-
sis. Post-dilatation esophagoscopy should always be per-
formed to rule out such lesions.
Two cases of massive bleeding were reported over the
26-year period of this series, one for a malignant and
another for a benign stricture in a patient treated with anti-
coagulants. Overall, the rate of severe hemorrhage was
0.11%.
Esophageal perforation represents the primary severe
complication of dilatation, with rapid progression to sepsis,
mediastinitis and death. Rapid diagnosis and aggressive
treatment are required. In our 26-year review, transmural
perforation occurred once in the group of benign strictures
because of faulty manipulation of the guide-wire, and 33
times in cases of malignant strictures. Overall, the perfora-
tion rate was 1.83, 0.09% for benign and 4.45% for malig-
nant strictures, respectively. The perforation rates in case of
malignant strictures included both perforations during the
dilatation procedure itself and during esophageal prosthesis
insertion.
All cases of death secondary to dilatation occurred in the
group of esophageal perforations with a fatal evolution in
seven patients. The overall mortality rate was thus 0.38,
0.09% for benign and 0.81% for malignant strictures,
respectively.
Our results show that the Savary-Gilliard technique for
esophageal dilatation of benign strictures is safe, with only
0.18% of severe complications. With a perforation rate of
0.09%, we are at the lower limit of the 0.1–0.4% rate cur-
rently reported in the literature for esophageal dilatation in
general [1, 8, 11]. The advantages of the Savary-Gilliard
technique include the progressive Xexibility of its guide-
wire and the tapered bougies exerting constant pressure on
the esophageal wall, which provides the surgeon with feed-
back concerning resistance during the procedure. Moreover,
all of the dilatations in our department were performed
under Xuoroscopy. This may also account for the reduced
rate of complications. In the literature, dilatations with the
Eder-Puestow olives are associated with higher perforation
rates, ranging from 0.4 to 0.9% [16, 36]. The large gradient
of pressure provoked by the form of these dilators and their
extremely Xexible guide-wire tip account for the higher per-
foration risk. This system is now obsolete. In the current lit-
erature, the perforation rate with the Maloney dilators is also
reported to be higher than that with the Savary-Gilliard bou-
gies. A study comparing perforation rates with Maloney,
balloon and Savary dilators showed no perforation for the
latter two procedures (156 and 90, respectively), and a 3.9%
perforation rate for the Maloney dilators in 102 procedures
[11]. Another prospective study of 300 patients dilated
either with the Maloney, Savary-Gilliard, Eder-Puestow or
balloon dilators, resulted in a single perforation, which
occurred with a Maloney dilator used in the absence of Xuo-
roscopy for dilatation of a Schatzki’s ring [35]. Blind dilata-
tion, as in the Maloney technique, increases the risk of
misdirection of the dilator resulting in tracheal intubation,
tearing or even perforation of the esophageal wall.
Finally, a randomized study by Cox et al. [5] showed
better improvement on stricture diameter using the Savary-
Gilliard or the Eder-Puestow bougies than with balloon
dilators. Safety of both methods was similar. Balloon dila-
tors are also more expensive and cannot be used more than
once. By contrast, Savary-Gilliard bougies may be reused
indeWnitely. At our institution, we are still using one of the
same set of bougies that was used in 1980 when the tech-
nique was Wrst developed. No problems with inter-individ-
ual contamination or infection have occurred.
In the case of malignant strictures, the perforation rate
increased to 4.45% in our cohort of patients because of
tearing of the tumor. However, this condition was often
successfully managed by immediate trans-tumoral intuba-
tion. In these cases, the prognosis was better than for perfo-
ration of benign strictures. The mortality rate in cases of
perforation of benign strictures was high (1/1 patient),
whereas mortality for perforation of malignant strictures
was 18% (6/33 patients). Tumoral inWltration surrounding
the esophagus and forming a barrier to the mediastinum
may account for the lower rate of bacterial dissemination
and subsequent sepsis after perforation of large tumors.
Conclusion
Esophageal strictures treated in our department were primar-
ily of iatrogenic origin (61%) since the decrease in preva-
lence of peptic strictures secondary to the introduction of
PPIs in 1989. Dilatation of benign strictures with the
Savary-Gilliard technique was safe, even for complex stric-
tures, with only two cases of severe complication out of a
total of 1,120 procedures. We advise the systematic use of
Xuoroscopy during dilatation as it probably contributes to
this low complication rate. Even if perforation is more likely
to occur in cases of malignant strictures, this complication is
usually well managed by esophageal prosthesis insertion.
Long-term eYciency of dilatation varies and is highly
dependent on the etiology of the stricture. Even in cases of
complex strictures, the median of 2–2.5 dilatations per
patient over the 17-year period reviewed, showed that the
overall eYcacy is good and provide a satisfactory quality of
life for most patients.123
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